Tirzepatide
Frequently Bought Together
Tirzepatide (CAS 2023788-19-2) is a synthetic dual-agonist peptide supplied for laboratory and analytical research use only, and one of the most frequently referenced compounds in contemporary metabolic research literature.
Research background
Tirzepatide is described in the literature as a dual GIP and GLP-1 receptor agonist. Its dual-receptor activity has made it a common reference compound in incretin research, where investigators study receptor binding behaviour, signalling pathways and comparative activity against single-agonist peptides in controlled research models.
Specifications
- Compound: Tirzepatide
- CAS number: 2023788-19-2
- Appearance: Lyophilised white powder
- Purity: 99%+ verified by HPLC-MS
- Available size: 20mg
- Presentation: Sealed, tamper-evident vial
Testing and verification
Every batch undergoes independent third-party HPLC-MS analysis confirming identity, quantity and purity. Each lot carries a unique batch identifier with its Certificate of Analysis published on our Lab Results page for full traceability.
Handling and storage
Supplied lyophilised. Store sealed vials cold and protected from light. Standard laboratory handling practices apply.
Research use only. This material is intended strictly for laboratory and analytical research. It is not a medicine, supplement or therapeutic good, and is not for human or veterinary consumption.
Frequently asked questions
What is tirzepatide 20mg used for in research?
Tirzepatide is a dual GIP/GLP-1 receptor agonist. It is used as a reference compound in incretin and metabolic research models to study receptor binding, signalling pathways and comparative activity against single-agonist peptides such as semaglutide and retatrutide.
How is purity verified?
Every batch is tested by an independent third-party lab using HPLC-MS (high-performance liquid chromatography with mass spectrometry), which confirms identity, quantity and purity. Each vial carries a batch number, and the matching Certificate of Analysis is published on our Lab Results page.
How should tirzepatide be stored?
Lyophilised (freeze-dried) peptide is stable when kept sealed, cold and protected from light. Once reconstituted with bacteriostatic water, keep the vial refrigerated and use within the window appropriate to your protocol. Avoid repeated freeze-thaw cycles.
How is it reconstituted?
Add bacteriostatic water slowly down the inside wall of the vial and let the powder dissolve on its own. Do not shake. Swirl gently if needed. The volume you add determines the final concentration, so record it with the batch number. Full walkthrough: How to Reconstitute Lyophilised Peptides.
How does tirzepatide differ from semaglutide and retatrutide?
Semaglutide is a single GLP-1 agonist, tirzepatide is a dual GIP/GLP-1 agonist, and retatrutide adds glucagon receptor activity (triple agonist). Researchers typically select based on which receptor pathways the study is examining. Read more in Retatrutide vs Tirzepatide: Receptor Targets Compared.
How does shipping work?
Orders are packed in sealed, tamper-evident vials. See our shipping policy for processing times and carriers. Lyophilised peptides do not require cold-chain shipping.
Is this for human use?
No. Everything we sell is supplied strictly for laboratory and analytical research. It is not a drug, supplement or therapeutic product and is not for human or veterinary use.
Compounds you might also study
Retatrutide
99%+HPLC